DEVEC metronomic schedule for aggressive B and T-cell lymphomas.

• DOI: 10.1200/jco.2018.36.15_suppl.7563
• Publication Date: 2018-09-05T10:42:41Z
• Authors: Maria Christina COX; Roberta Battistini; Sabrina Pelliccia; Annalisa Arcari; Paola Anticoli Borza; Ivana Casaroli; Valerio Zoli; Francesca Di Landro; Francesca Fabbri; Giulia Galassi; Anna Paola Leporace; Monica Piedimonte; Marco Di Girolamo; Daniela Prosperi; Alessia Campagna; Arianna Di Napoli; Agostino Tafuri; Guido Bocci; Gerardo Musuraca
• Keywords: 03 medical and health sciences; 0302 clinical medicine; 3. Good health

7563Background: Metronomic chemotherapy (MC) is an emerging approach in solid tumours. Since MC has been poorly investigated in aggressive lymphomas in 2011, we formulated a new oral MC regimen ter...